These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39408277)

  • 21. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
    Iyer KR; Kunecki M; Boullata JI; Fujioka K; Joly F; Gabe S; Pape UF; Schneider SM; Virgili Casas MN; Ziegler TR; Li B; Youssef NN; Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):946-951. PubMed ID: 27875291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
    Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
    Clin Nutr; 2020 Aug; 39(8):2479-2486. PubMed ID: 31784300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term Effects of Teduglutide on Intestinal Mucosa in a Patient With Crohn's Disease and Short Bowel Syndrome: Clinical, Endoscopic and Histological Data Compared.
    Borghini R; Villanacci V; Oberti A; Caronna R; Trecca A
    Inflamm Bowel Dis; 2021 Nov; 27(12):e152-e153. PubMed ID: 34255043
    [No Abstract]   [Full Text] [Related]  

  • 24. Short bowel syndrome and Crohn's disease.
    Thompson JS; Iyer KR; DiBaise JK; Young RL; Brown CR; Langnas AN
    J Gastrointest Surg; 2003 Dec; 7(8):1069-72. PubMed ID: 14675717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The indications and results of the use of teduglutide in patients with short bowel.
    El Khatib M; Billiauws L; Joly F
    Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):449-454. PubMed ID: 37421385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for short bowel syndrome in patients with Crohn's disease.
    Uchino M; Ikeuchi H; Bando T; Matsuoka H; Takahashi Y; Takesue Y; Matsumoto T; Tomita N
    Surg Today; 2012 May; 42(5):447-52. PubMed ID: 22173650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
    Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
    Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
    Seidner DL; Fujioka K; Boullata JI; Iyer K; Lee HM; Ziegler TR
    Nutr Clin Pract; 2018 Aug; 33(4):520-527. PubMed ID: 29761915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
    Chen K; Mu F; Xie J; Kelkar SS; Olivier C; Signorovitch J; Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2020 Jan; 44(1):119-128. PubMed ID: 31006876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study.
    Joly F; Seguy D; Nuzzo A; Chambrier C; Beau P; Poullenot F; Thibault R; Armengol Debeir L; Layec S; Boehm V; Lallemand J; Quilliot D; Schneider SM
    Clin Nutr; 2020 Sep; 39(9):2856-2862. PubMed ID: 31932048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
    Pevny S; Maasberg S; Rieger A; Karber M; Blüthner E; Knappe-Drzikova B; Thurmann D; Büttner J; Weylandt KH; Wiedenmann B; Müller VA; Bläker H; Pascher A; Pape UF
    Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Intestinal Failure in Children: An International Multicenter Cross-Sectional Survey.
    Lezo A; Diamanti A; Marinier EM; Tabbers M; Guz-Mark A; Gandullia P; Spagnuolo MI; Protheroe S; Peretti N; Merras-Salmio L; Hulst JM; Kolaček S; Ee LC; Lawrence J; Hind J; D'Antiga L; Verlato G; Pukite I; Di Leo G; Vanuytsel T; Doitchinova-Simeonova MK; Ellegard L; Masconale L; Maíz-Jiménez M; Cooper SC; Brillanti G; Nardi E; Sasdelli AS; Lal S; Pironi L
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.
    Yazbeck R
    Curr Opin Mol Ther; 2010 Dec; 12(6):798-809. PubMed ID: 21154171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The current therapeutic options for Crohn's disease: from medical therapy to intestinal transplantation.
    Lauro A; D'Amico F; Gondolesi G
    Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1105-1117. PubMed ID: 28805088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Candidacy of adult patients with short bowel syndrome for treatment with glucagon-like peptide-2 analogues: A systematic analysis of a single centre cohort.
    Pironi L; Sasdelli AS; Venerito FM; Musio A; Pazzeschi C; Guidetti M
    Clin Nutr; 2021 Jun; 40(6):4065-4074. PubMed ID: 33637328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crohn's Disease and Intestinal Transplantation.
    Drastich P; Oliverius M
    Dig Dis; 2017; 35(1-2):127-133. PubMed ID: 28147371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First registry of adult patients with chronic intestinal failure due to short bowel syndrome in Argentina: The RESTORE project.
    Gondolesi GE; Ortega ML; Doeyo M; Buncuga M; Pérez C; Mauriño E; Costa F; De Barrio S; Manzur A; Donnadio L; Matoso D; Sánchez Claria R; Crivelli A; Solar H
    JPEN J Parenter Enteral Nutr; 2022 Sep; 46(7):1623-1631. PubMed ID: 35511709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice-Real-world evidence from the inflammatory bowel diseases-podcast study.
    D'Amico F; Gomollón F; Bamias G; Magro F; Targownik L; Leitner C; Heatta-Speicher T; Michelena N; Kolterer S; Lapthorn J; Kauffman L; Dignass A;
    United European Gastroenterol J; 2024 Jul; 12(6):705-716. PubMed ID: 38733307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
    Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.